Press Release: European Medicines Agency recommends first medical treatment for patients with short bowel syndrome

Author (Corporate)
Series Title
Series Details EMA/CHMP/409283/2012 (22.6.12)
Publication Date 22/06/2012
Content Type

The European Medicines Agency (EMA), on 22 June 2012, recommended approval of Revestive (teduglutide) for the treatment of adult patients with short bowel syndrome. This is the first medical treatment recommended for approval in Europe in this rare but seriously debilitating condition.
Source Link http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/06/news_detail_001545.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/CHMP/409283/2012 (22.6.12): European Medicines Agency recommends first medical treatment for patients with short bowel syndrome http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2012/06/WC500129107.pdf
Subject Categories
Countries / Regions